abstract
- GIM/FP/GP: [Formula: see text] Infectious Disease: [Formula: see text] Pulmonology: [Formula: see text].
In rifampicin-resistant TB, bedaquiline-containing regimens reduced unfavorable status vs. a control regimen at 132 wk.
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
authors
status
publication date
- February 2025
has subject area
- 1103 Clinical Sciences (FoR)
- 1117 Public Health and Health Services (FoR)
- Adult (MeSH)
- Antitubercular Agents (MeSH)
- Diarylquinolines (MeSH)
- Drug Therapy, Combination (MeSH)
- Female (MeSH)
- Humans (MeSH)
- Male (MeSH)
- Middle Aged (MeSH)
- Rifampin (MeSH)
- Tuberculosis, Multidrug-Resistant (MeSH)
published in
- ACP journal club Journal